//
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey
The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short
Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial
Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study
A randomized comparison of Coronary Stents according to Short or Prolonged durations of Dual Antiplatelet Therapy in patients with Acute Coronary Syndromes: a pre-specified analysis of the SMART-DATE trial